Warning: This security is no longer trading.
Allergan plc Ordinary Shares (AGN): Price and Financial Metrics
Allergan plc Ordinary Shares (AGN):
GET POWR RATINGS...
AGN Stock Summary With a market capitalization of $63,659,113,779, Allergan plc has a greater market value than 97.39% of US stocks. AGN's went public 30.91 years ago, making it older than 88.57% of listed US stocks we're tracking. The volatility of Allergan plc's share price is greater than that of just 2.61% US stocks with at least 200 days of trading history. If you're looking for stocks that are quantitatively similar to Allergan plc, a group of peers worth examining would be PTR, SNP, CAT, BSX, and BDX. AGN's SEC filings can be seen here. And to visit Allergan plc's official web site, go to www.allergan.com.
AGN Price/Volume Stats
Allergan plc Ordinary Shares (AGN) Company Bio
Allergan plc markets products that provide treatments for the central nervous system, eye care, medical aesthetics, gastroenterology, women's health, urology, cardiovascular and anti-infective therapeutic categories, and operates the world's third-largest global generics business. The company was founded in 1983 and is based in Parsippany, New Jersey.
AGN Latest News Stream
All News Types
Loading, please wait...
Latest AGN News From Around the Web
Below are the latest news stories about Allergan plc that investors may wish to consider to help them evaluate AGN as an investment opportunity.
Founder of Renaissance Technologies releases portfolio update Continue reading...
AbbVie is rallying now that the company has closed its mega-deal with Allergan. The stock is looking to possibly test 2020 highs.
Read More 'AGN' Stories Here
AGN Price Returns
Page generated in 1.3812 seconds.